Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 Jul 20;19(8):2073–2079. doi: 10.1158/1055-9965.EPI-10-0428

Table 4.

Ever oral contraceptive use in relation to ER+PR+ and ER-PR- cancer according to categories of breast cancer risk factors

ER+PR+
ER−PR−
Risk factor OC use ever/never (no. cases) IRR* 95% CI P* OC use ever/never (no. cases) IRR 95% CI P**
Age <50 144/23 1.28 (0.82–2.00) 0.07 119/14 1.80 (1.03–3.15) 0.87
  50+ 140/70 1.04 (0.77–1.41) 114/32 1.59 (1.05–2.41)
Premenopausal 130/19 1.36 (0.84–2.21) 0.14 106/15 1.49 (0.86–2.57) 0.75
Postmenopausal 112/27 0.95 (0.69–1.31) 90/27 1.66 (1.05–2.62)
BMI at age 18<20 134/43 0.89 (0.61–1.29) 0.55 116/25 1.43 (0.91–2.25) 0.42
      20+ 146/57 1.10 (0.79–1.54) 116/21 1.85 (1.14–3.01)
BMI current <25 69/19 0.94 (0.55–1.61) 0.35 62/11 1.53 (0.78–2.98) 0.97
      25+ 214/83 1.13 (0.85–1.49) 171/35 1.67 (1.14–2.44)
Age menarche <12 77/28 1.05 (0.65–1.69) 0.90 77/18 1.41 (0.82–2.44) 0.41
       12+ 206/74 1.10 (0.82–1.47) 156/28 1.79 (1.18–2.73)
Age 1st birth <20 62/29 0.99 (0.61–1.61) 0.44 57/14 1.56 (0.84–2.90) 0.25
      20+ 150/47 1.02 (0.71–1.46) 140/18 2.18 (1.31–3.62)
Parity 0 72/24 1.54 (0.91–2.61) 0.33 34/14 1.00 (0.50–1.98) 0.06
   1+ 212/78 0.99 (0.75–1.32) 198/32 1.92 (1.30–2.83)
Female.hormone use never 184/51 1.19 (0.85–1.66) 0.29 165/24 2.05 (1.32–3.19) 0.12
         ever 98/49 1.04 (0.69–1.45) 68/21 1.26 (0.74–2.14
Family history No 229/85 1.39 (0.77–2.54) 0.24 194/39 2.15 (0.93–4.98) 0.55
       Yes 55/17 1.04 (0.79–1.37) 39/7 1.59 (1.10–2.28)
Cigarette smoking never 170/54 1.23 (0.88–1.72) 0.59 141/26 1.53 (0.99–2.35) 0.75
        ever 114/47 1.01 (0.69–1.47) 92/20 1.83 (1.09–3.08)
Alcohol drinks/wk <1 207/78 1.08 (0.81–1.43) 0.82 169/38 1.42 (0.98–2.05) 0.49
        1+ 77/24 1.16 (0.69–1.94) 64/8 2.81 (1.29–6.09)
Vigorous exercise No 159/59 1.25 (0.90–1.74) 0.24 131/30 1.59 (1.05–2.42) 0.72
        Yes 122/41 0.89 (0.61–1.31) 101/15 1.82 (1.04–3.21)
Education years <16 143/49 1.39 (0.97–1.99) 0.15 139/29 1.77 (1.16–2.70) 0.44
       16+ 141/53 0.87 (0.62–1.23) 102/17 1.55 (1.07–2.31)
*

Never use of oral contraceptives is the reference category; IRRs adjusted for age, age at menarche, BMI at age 18, family history of breast cancer, education, parity, age at first birth, menopausal status, age at menopause, menopausal hormone use, vigorous activity, alcohol intake.

**

P value for interaction